FinDogFinDog
Friday, October 30, 2026Closing data · 4:00 PM ET
English
Log in

HSIC

Henry ScheinNASDAQ · Health Care Distributors · Health Care
Previous close
84.88
Change
−1.56 / −1.80%
FinDog View
Bullish
52-Week Range ?
62.32 – 92.18
P/E (TTM) ?
23.5
Forward P/E ?
15.1
Based on consensus earnings for the next 12 months
Market Cap
$9.5B
1M
+1.08%
S&P 500 −0.91% over same period
Volume / Avg Volume
1.2M / 1.1M
1.05× average
Latest earnings analysisFY2026 Q2Reported 2026-08-04

Henry Schein Q2 FY2026: sales up 6.7%, FY guidance raised

Henry Schein's fiscal 2026 second quarter was a solid operating beat: sales rose 6.7% to $3.458 billion, gross margin held at 31.8%, and the company raised full-year guidance. The catch is that GAAP profit stayed thin at $94 million, just 2.7% of sales. Read this as improving operations, not as a high-margin business suddenly emerging.

Read the full analysis →
Revenue$3.46BYoY +6.70%
EPS (non-GAAP)$1.27Beatest. $1.26
Next-day move+0.54%

Price History

Closing price · USD1M6M1Y5Y
60708090100EEEEEE2021-102023-012024-042025-082026-10

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 24.71M6M1Y5Y
24.324.524.82525.325.52026-092026-102026-102026-102026-10

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis

Next Earnings

Date and consensus from the earnings calendar; the analysis is generated automatically after the releaseEarnings Calendar →
Report date
2026-11-02
Tomorrow · Pre-market
Consensus EPS
$1.38
Last quarter EPS $1.27
Avg. next-day move over the last 6 reports
±1.4%

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
P/E is at percentile 54 of its 5-year rangeMid-range
5-year range 20.4 – 29.2 · Median 23.1
Last 4 quarters: $728M in buybacks + $0 in dividends, 7.69% of market cap combined
P/E (TTM)
23.5
P/B
3.0
P/S
0.7
PEG
1.48
Earnings Reaction
Over the last 6 reports, the stock moved ±1.4% on average on the first trading day after, rising 3 times
Most recent +0.54%
Volatility & Correlation
1-year beta 0.46 · Correlation with S&P 500 0.23Low beta
Annualized volatility 26% vs. 13% for the S&P 500
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
No open-market buys or sells by officers or directors in the last 90 days.
Multi-Quarter Financial Trends
View all quarters →
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q23.46+6.7%31.8%0.170.090.240.82
FY2026 Q13.37+6.3%31.8%0.180.11-0.100.92
FY2025 Q43.44+7.7%30.9%0.160.120.380.85
FY2025 Q33.34+5.2%30.7%0.160.100.170.84
FY2025 Q23.24+3.3%31.4%0.150.090.120.70
FY2025 Q13.17−0.1%31.6%0.180.110.040.88
FY2024 Q43.19+5.8%31.1%0.160.100.200.75
FY2024 Q33.17+0.4%31.3%0.160.100.150.78
FY2024 Q23.14+1.2%32.5%0.160.100.300.80
FY2024 Q13.17+3.7%31.9%0.150.090.200.72
FY2023 Q43.02−10.5%30.6%0.040.04-0.030.14
FY2023 Q33.16+3.1%31.5%0.200.140.231.05

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView